EP2319517
Notkun forlyfja til lyfjagjafar með inndælingu í auga
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
1.6.2006EP published:
11.9.2013EP application number:
10177382.8
EP translation filed:
29.11.2013Grant published:
15.12.2013EPO information:
European Patent Register
Max expiry date:
31.5.2026Expiry date:
31.5.2022
Title:
Use of prodrugs for ocular intravitreous administration
Timeline
Today
1.6.2006EP application
11.9.2013EP Publication
29.11.2013Translation submitted
15.12.2013Registration published
31.5.2022Expires
Owner
Name:
SANTEN SASAddress:
1 rue Pierre Fontaine Batiment Genavenir IV, F-91000, Evry, FR
Inventor
Name:
Rabinovich-Guilatt, LauraAddress:
Kadima, IL
Name:
Lambert, GrégoryAddress:
Châtenay-Malabry, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
06290902Date:
1.6.2006Country:
EP
Classification
Categories:
A61K 31/573, A61K 47/48, A61P 27/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 21.5.2014
Expires: 31.5.2015
Payer: G. H. Sigurgeirsson
Number: 10
Paid: 20.5.2015
Expires: 31.5.2016
Payer: G. H. Sigurgeirsson
Number: 11
Paid: 19.5.2016
Expires: 31.5.2017
Payer: G. H. Sigurgeirsson
Number: 12
Paid: 19.5.2017
Expires: 31.5.2018
Payer: G. H. Sigurgeirsson
Number: 13
Paid: 14.6.2018
Expires: 31.5.2019
Payer: G. H. Sigurgeirsson
Number: 14
Paid: 21.5.2019
Expires: 31.5.2020
Payer: G. H. Sigurgeirsson
Number: 15
Paid: 10.6.2020
Expires: 31.5.2021
Payer: G.H. Sigurgeirsson ehf.
Number: 16
Paid: 10.6.2021
Expires: 31.5.2022
Payer: G.H. Sigurgeirsson ehf.